• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of June 7, 2023

    FDA

    Generic Drugmaker Admits to Price Fixing

    RAPS

    When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price

    PROPUBLICA

    These 10 Drugs Are Busting Hospital Budgets

    FORBES

    Mylan Launches Generic Apresoline® Injection

    PR NEWSWIRE

    X-Gen`s Generic Hydralazine Hcl (20Mg/Ml) Approved in US For Hypertension

    FDA

    Par Pharmaceutical Inc., Ongoing Class II recall of HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Rx only, Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY10977 because of Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small aluminum particles.

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.